Company intelligence / Profile preview

NeuroTrader

Delaware, USA

Ownership: Private
Development stage: Other

Overview

NeuroTrader is a neurotechnology company that develops behavior-driven performance intelligence solutions for financial traders. The company leverages wearable EEG devices and neurofeedback software to monitor and analyze brain activity, helping traders manage emotions, improve discipline, and optimize decision-making. By integrating neuroscience with trading performance, NeuroTrader aims to bridge the gap between cognitive state and execution consistency in high-pressure financial environments. Its platform provides real-time behavioral diagnostics and cognitive training to enhance the "trader's edge" through improved mental performance.

Therapeutic areas: PsychiatryNeurology
Modalities: NeurofeedbackEEGDigital Health PlatformWearable Device
Industry: Physiological Monitoring

Partnerships

ICODA (Marketing)Emotiv (Hardware)Muse (Hardware)

Beyond the preview

Go deeper on NeuroTrader.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroTrader.

Explore the full profile